Neuberger Berman Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$234M |
| 2 |
Gilead Sciences
GILD
|
+$172M |
| 3 |
CVS Health
CVS
|
+$169M |
| 4 |
Public Service Enterprise Group
PEG
|
+$158M |
| 5 |
Bank of America
BAC
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$338M |
| 2 |
JPMorgan Chase
JPM
|
+$288M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$276M |
| 4 |
Medtronic
MDT
|
+$257M |
| 5 |
Advanced Micro Devices
AMD
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.43% |
| 2 | Healthcare | 12.6% |
| 3 | Financials | 12.53% |
| 4 | Industrials | 10.94% |
| 5 | Consumer Discretionary | 8.78% |
Similar funds
Neuberger Berman Group's Q4 2023 Portfolio in Review
As of Q4 2023, Neuberger Berman Group held 1,953 positions worth $115B, up 4.5% from $110B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Neuberger Berman Group withdrew a net $5.87B in Q4 2023, closing 90 positions and reducing 931 holdings. Its most notable exit was Activision Blizzard, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Neuberger Berman Group opened a new position in Avantis Emerging Markets Equity ETF worth $27.4M.
- Neuberger Berman Group's largest Q4 2023 buy was Avantis Emerging Markets Equity ETF: 486,139 shares worth $27.4M.
- Neuberger Berman Group added most to UnitedHealth in Q4 2023, an estimated $234M increase.
- Neuberger Berman Group's biggest Q4 2023 reduction was Chevron, cutting an estimated $338M.
- Neuberger Berman Group fully exited Activision Blizzard in Q4 2023, selling an estimated $276M.
- Neuberger Berman Group's ten largest holdings make up 17% of its $115B portfolio in Q4 2023.
- Neuberger Berman Group opened 141 new positions and closed 90 in Q4 2023.
- Neuberger Berman Group's portfolio value rose 4.5% quarter-over-quarter to $115B.
Based on Neuberger Berman Group's 13F filing for Q4 2023, filed 9 Feb 2024.